Show simple item record

dc.rights.licenseopenen_US
hal.structure.identifierInstitut des Maladies Neurodégénératives [Bordeaux] [IMN]
dc.contributor.authorAROTCARENA, Marie Laure
hal.structure.identifierInstitut des Maladies Neurodégénératives [Bordeaux] [IMN]
dc.contributor.authorDOVERO, Sandra
hal.structure.identifierInstitut des Maladies Neurodégénératives [Bordeaux] [IMN]
dc.contributor.authorBIENDON, Nathalie
hal.structure.identifierInstitut des Maladies Neurodégénératives [Bordeaux] [IMN]
dc.contributor.authorDUTHEIL, Nathalie
hal.structure.identifierInstitut des Maladies Neurodégénératives [Bordeaux] [IMN]
dc.contributor.authorPLANCHE, Vincent
hal.structure.identifierInstitut des Maladies Neurodégénératives [Bordeaux] [IMN]
dc.contributor.authorBEZARD, Erwan
hal.structure.identifierInstitut des Maladies Neurodégénératives [Bordeaux] [IMN]
dc.contributor.authorDEHAY, Benjamin
dc.date.accessioned2022-10-10T09:01:59Z
dc.date.available2022-10-10T09:01:59Z
dc.date.issued2021-11-15
dc.identifier.issn2296-4185en_US
dc.identifier.urioai:crossref.org:10.3389/fbioe.2021.762209
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/148369
dc.description.abstractEnAdeno-associated virus (AAV) vectors are increasingly used as an effective and safe approach to deliver genetic material to the central nervous system (CNS). The AAV9-derived variants, AAV-PHP. B and AAV-PHP.eB, reportedly broadly transduce cells throughout the CNS compared to the original serotype 9, AAV9. As non-human primate data are scarce, we here evaluated the CNS transduction efficiencies after lumbar intrathecal bolus delivery of identical doses of either AAV-PHP. B:CAG-EGFP or AAV-PHP. eB:CAG-EGFP in rhesus macaque monkeys. AAV-PHP.eB achieved a more efficient and widespread CNS transduction compared to AAV-PHP.B. We report a strong neuronal and oligodendroglial tropism for both variants in the putamen and in the hippocampus. This proof-of-concept experiment highlights the potential value of intrathecal infusions of AAV-PHP.eB to distribute genetic material in the CNS with cell-type specificity and introduces a new opportunity to model brain diseases in rhesus macaque monkeys and further develop gene therapies targeting the CNS in humans.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.sourcecrossref
dc.subject.enAdeno-associated virus
dc.subject.enIntrathecal injection
dc.subject.enCNS
dc.subject.enNon-human primate
dc.subject.enAnimal model
dc.title.enPilot Study Assessing the Impact of Intrathecal Administration of Variants AAV-PHP.B and AAV-PHP.eB on Brain Transduction in Adult Rhesus Macaques
dc.typeArticle de revueen_US
dc.identifier.doi10.3389/fbioe.2021.762209en_US
dc.subject.halSciences du Vivant [q-bio]en_US
dc.identifier.pubmed34869273en_US
bordeaux.journalFrontiers in Bioengineering and Biotechnologyen_US
bordeaux.volume9en_US
bordeaux.hal.laboratoriesInstitut des Maladies Neurodégénératives (IMN) - UMR 5293en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDMinistère de l'Enseignement supérieur, de la Recherche et de l'Innovationen_US
bordeaux.identifier.funderIDAssociation France Parkinsonen_US
bordeaux.identifier.funderIDUniversité de Bordeauxen_US
bordeaux.identifier.funderIDCentre National de la Recherche Scientifiqueen_US
bordeaux.import.sourcedissemin
hal.identifierinserm-03429973
hal.version1
hal.exportfalse
workflow.import.sourcedissemin
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers%20in%20Bioengineering%20and%20Biotechnology&rft.date=2021-11-15&rft.volume=9&rft.eissn=2296-4185&rft.issn=2296-4185&rft.au=AROTCARENA,%20Marie%20Laure&DOVERO,%20Sandra&BIENDON,%20Nathalie&DUTHEIL,%20Nathalie&PLANCHE,%20Vincent&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record